Evolutions in our understanding of endocrine disrupting chemicals during pregnancy
Chicago, Illinois | September 27, 2023
Elsevier’s Molecular and Cellular Endocrinology (MCE) journal published a new special issue: Mother, placenta, and fetal health: Endocrine Disrupting Chemicals at play
We are exposed to numerous chemicals throughout our livespans. The most critical window of expsure is pregnancy, a time when not only the developing individual, but also the mother, are extremely sensitive to endocrine disruption The 7 articles contained in this Special Issue published in Elsevier’s Molecular and Cellular Endocrinology journal cover environmental and chemical exposures from conception throughout pregnancy.

This collection of articles examines different aspects and effects of environmental and chemical endocrine disruptions during pregnancy. Its ground breaking topics pertain to: effects of temperature and stress on fetal growth, nanoparticles at the maternal-fetal interface, pregnancy related maternal physiological adaptations and fetal chemical exposure, toxicity of prenatal exposures to endocrine disrupting chemicals, toxicity and placental cells, immunological and metabolic status of women exposed to EDCs, animal studies pertaining to placenta-brain axis disruption from chemical exposure.

Fig 1. Illustration of putative mechanisms that may underlie associations between heat stress during pregnancy and restricted fetal growth. Ambient temperature, heat stress and fetal growth: A review of placenta-mediated mechanisms

Fig 2. Overview of maternal adaptations in pregnancy. Pregnancy-related maternal physiological adaptations and fetal chemical exposure
Quote from the Comissioning Editor’s: “Pregnancy is among the most vulnerable periods in a woman’s lifetime. It is well established that environmental exposures during pregnancy can have adverse impacts on the maternal-fetal interface with effects spanning the placenta, the fetus, and the mother, at a time during which most of her organs undergo critical adaptations. Most chemicals in addition to bathing the placental bed and having a direct impact on placental function also cross the placental barrier reaching the fetus and posing a developmental risk. This Special Issue assembles a series of works that review the state of the art regarding pregnancy exposures and the impact on maternal-fetal interface that can underlie pregnancy disorders and fetal outcomes.”
This research addressing the growing need for more nuanced and complex understandings of how our bodies interact with their environments. Nothing could be more fundamental to this interaction than pregnancy itself. While these articles do not paint the entire picture of endocrine distrupting chemicals (EDC) and pregnancy, they do begin a more serious and focused dialogue that should serve as a stepping stone for future advancements in the field.
The articles contained in this special issue are:
“Ambient temperature, heat stress and fetal growth: A review of placenta-mediated mechanisms” Whitney Cowell, Natasha Ard, Teresa Herrera, Eleanor A. Medley, Leonardo Trasande (https://doi.org/10.1016/j.mce.2023.112000) Molecular and Cellular Endocrinology, volume 576, October 2023, published by Elsevier.
“Nanoparticles at the maternal-fetal interface” S. Adams, P.A. Stapleton (https://doi.org/10.1016/j.mce.2023.112067) Molecular and Cellular Endocrinology, Article in Press 2023, published by Elsevier.
“Pregnancy-related maternal physiological adaptations and fetal chemical exposure” Marie-Therese Vinnars, Marie Bixo, Pauliina Damdimopoulou (https://doi.org/10.1016/j.mce.2023.112064) Molecular and Cellular Endocrinology, volume 578, December 2023, published by Elsevier.
“Prenatal exposures to endocrine disrupting chemicals: The role of multi-omics in understanding toxicity” Margaret H. Rabotnick, Jessa Ehlinger, Ariana Haidari, Jaclyn M. Goodrich (https://doi.org/10.1016/j.mce.2023.112046) Molecular and Cellular Endocrinology, volume 578, December 2023, published by Elsevier.
“Placental single cell transcriptomics: Opportunities for endocrine disrupting chemical toxicology” Elana R. Elkin, Kyle A. Campbell, Samantha Lapehn, Sean M. Harris, ... Alison G. Paquette (https://doi.org/10.1016/j.mce.2023.112066) Molecular and Cellular Endocrinology, Article in Press 2023, published by Elsevier.
“Exposure to endocrine disrupting chemicals impacts immunological and metabolic status of women during pregnancy” Alyssa K. Merrill, Marissa Sobolewski, Martha Susiarjo (https://doi.org/10.1016/j.mce.2023.112031) Molecular and Cellular Endocrinology, volume 577, November 2023, published by Elsevier.
“Gestational exposure to FireMaster® 550 (FM 550) disrupts the placenta-brain axis in a socially monogamous rodent species, the prairie vole (Microtus ochrogaster)” William P. Marinello, Sagi Enicole A. Gillera, Yoonhee Han, Jason R. Richardson, ... Heather B. Patisaul (https://doi.org/10.1016/j.mce.2023.112041) Molecular and Cellular Endocrinology, volume 576, October 2023, published by Elsevier.
Copies of these papers are available to credentialed journalists upon request; please contact Daniel Martin at [email protected]
About Molecular and Cellular Endocrinology (MCE)
Molecular and Cellular Endocrinology was established in 1974 to meet the demand for integrated publication on all aspects related to the genetic and biochemical effects, synthesis and secretions of extracellular signals (hormones, neurotransmitters, etc.) and to the understanding of cellular regulatory mechanisms involved in hormonal control.
About Elsevier
Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.
Media contact
DM